公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务

格隆汇05-27

【热点】雄韬股份(002733.SZ)：韬定律相关概念与公司主营业务不存在关联关系凯恩股份(002012.SZ)：公司不包括电解电容器纸业务华电辽能(600396.SH)：不涉及算电协同项目*ST宝馨(002514.SZ)：不涉及与“机器人”企业借壳、重整等洽谈或谈判的相关行为华塑控股(000509.SZ)：未从事PCB生产业务真视通(002771.SZ)：液冷和高压快充业务占公司总收入比例较低【...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2638689303?lang=zh_CN&edition=full","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","is_english":false,"pubTime":"2026-05-27 22:33","share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","id":"2638689303","market":"fut","top_or_hot":-1,"title":"公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务","media":"格隆汇","content":"<div>\n<p>【热点】雄韬股份(002733.SZ)：韬定律相关概念与公司主营业务不存在关联关系凯恩股份(002012.SZ)：公司不包括电解电容器纸业务华电辽能(600396.SH)：不涉及算电协同项目*ST宝馨(002514.SZ)：不涉及与“机器人”企业借壳、重整等洽谈或谈判的相关行为华塑控股(000509.SZ)：未从事PCB生产业务真视通(002771.SZ)：液冷和高压快充业务占公司总收入比例较低【...</p>\n\n<a href=\"https://www.gelonghui.com/p/4950239\">网页链接</a>\n\n</div>\n","source":"gelonghui_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n公告精选︱康龙化成：拟20亿元新建新药商业化生产和CDMO研发生产服务基地；华塑控股：未从事PCB生产业务\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-27 22:33 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.gelonghui.com/p/4950239><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【热点】雄韬股份(002733.SZ)：韬定律相关概念与公司主营业务不存在关联关系凯恩股份(002012.SZ)：公司不包括电解电容器纸业务华电辽能(600396.SH)：不涉及算电协同项目*ST宝馨(002514.SZ)：不涉及与“机器人”企业借壳、重整等洽谈或谈判的相关行为华塑控股(000509.SZ)：未从事PCB生产业务真视通(002771.SZ)：液冷和高压快充业务占公司总收入比例较低【...</p>\n\n<a href=\"https://www.gelonghui.com/p/4950239\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.gelonghui.com/p/4950239","article_id":"2638689303","we_media_id":null,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2638689303","pubTimestamp":1779892385,"columns":[],"sourceInfo":{"source_id":"gelonghui_highlight","name":"格隆汇"},"weMediaInfo":null,"summary":"龙芯中科：拟定增募资不超23亿元","collect":0,"end_time":0,"defaultTopTitle":"gelonghui.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300759":"康龙化成","BK4139":"生物科技","BK0095":"互联网金融","PCB":"PCB Bancorp","BK1141":"生命科学工具和服务","CDMO":"Avid Bioservices, Inc.","BK0145":"装饰园林","BK1576":"医药外包概念","BK0216":"研究试验","000509":"华塑控股","03759":"康龙化成","BK4211":"区域性银行","BK0236":"卫生","BK0102":"重组"},"translate_title":"Announcement Selection | Kanglong Chemical: It plans to build a new drug commercial production and CDMO R&D and production service base for 2 billion yuan; Huasu Holdings: Not engaged in PCB production business","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1.5,"CDMO":1.5,"PCB":1.5,"000509":1.5,"03759":1.5},"content_text":"【热点】雄韬股份(002733.SZ)：韬定律相关概念与公司主营业务不存在关联关系凯恩股份(002012.SZ)：公司不包括电解电容器纸业务华电辽能(600396.SH)：不涉及算电协同项目*ST宝馨(002514.SZ)：不涉及与“机器人”企业借壳、重整等洽谈或谈判的相关行为华塑控股(000509.SZ)：未从事PCB生产业务真视通(002771.SZ)：液冷和高压快充业务占公司总收入比例较低【项目投资】康龙化成(300759.SZ)：拟20亿元新建新药商业化生产和CDMO研发生产服务基地康龙化成(300759.SZ)：拟投资建设年产200吨医药中间体及API项目【中标合同】金螳螂(002081.SZ)：中标2.94亿元工程工大高科(688367.SH)：中标2165.56万元设备采购及安装项目通达股份(002560.SZ)：预中标共计1.76亿元国家电网项目【股权转让】恩捷股份(002812.SZ)：子公司拟收购江苏爱思开100%股权天洋新材(603330.SH)：拟向受让方转让德法瑞100%股权【回购】百联股份(600827.SH)：拟斥资1亿元-2亿元回购公司股份优宁维(301166.SZ)：拟回购1500万元-3000万元公司股份亿帆医药(002019.SZ)：拟1亿元-1.2亿元回购股份大北农(002385.SZ)：拟回购5000万元-8000万元公司股份密尔克卫(603713.SH)：拟斥资8000万元-1.2亿元回购股份【增减持】*ST国化(600636.SH)：中文发集团拟增持2%-3.86%股份龙利得(300883.SZ)：龙尔利拟增持5600万元-6000万元公司股份至纯科技(603690.SH)：控股股东蒋渊及其一致行动人拟减持不超3.00%股份【其他】江苏索普(600746.SH)：拟定增募资不超16亿元龙芯中科(688047.SH)：拟定增募资不超23亿元","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2638689303","isCrawlerRequest":true}